Aquatic Capital Management LLC Oncolytics Biotech Inc Transaction History

Aquatic Capital Management LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.85 - $1.59 $595 - $1,113	-700 Reduced 53.85%	600 $1,000
Q1 2022 May 16, 2022	SELL	$1.31 - $2.02 $1,703 - $2,626	-1,300 Reduced 50.0%	1,300 $2,000
Q4 2021 Feb 14, 2022	BUY	$1.39 - $2.3 $3,613 - $5,979	2,600 New	2,600 $4,000

1.24M

Ticker ONCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 57,867,400
Market Cap $45.7M
Description
Oncolytics Biotech Inc., a development-stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. Its lead product is pelareorep, an intravenously delivered immunotherapeutic agent for the treatment of solid tumors and hematological malignancies. Oncolytics Biotech Inc. has a...

Get notified when there are updates to the investment portfolio of Aquatic Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Aquatic Capital Management LLC with notifications on news.